71 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
by such person immediately prior to the consummation of such Fundamental Transaction by making a cash payment in an amount equal to the Black Scholes
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
to the Black Scholes Value of the remaining unexercised portion of such registered holder’s Warrants.
We might not be able to maintain the listing of our
8-K
EX-10.3
oauayerp
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
e2t6ry816qxui7
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
DEFA14A
1xe v5q3i295
21 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-4.2
rdnb 30r2n
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
8b4g0m
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
w8ytkxi5mhhsm45
28 Mar 22
Prospectus supplement for primary offering
4:53pm